Ohio Public Employees Retirement System (OPERS)’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
Other funds holding RETA
CI
PA
FLAM
BC
DTC
Ohio Public Employees Retirement System (OPERS)'s RETA Position: Q1 2023 in Review
Ohio Public Employees Retirement System (OPERS) sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q1 2023, closing a stake of 4,414 shares — an estimated $168K sold.
Ohio Public Employees Retirement System (OPERS) first reported a position in RETA in Q2 2020 and held it in 6 quarters. The position peaked at $1.46M in Q4 2020. 205 funds tracked by Wall St. Rank hold RETA as of Q1 2023.
- Ohio Public Employees Retirement System (OPERS) reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
- Ohio Public Employees Retirement System (OPERS) sold 4,414 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q1 2023, an estimated $168K.
- Ohio Public Employees Retirement System (OPERS) first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q2 2020 and held it in 6 quarters.
- Ohio Public Employees Retirement System (OPERS)'s Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $1.46M in Q4 2020.
- 205 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q1 2023.
Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q1 2023, filed 15 May 2023.